One Health Group PLC - Director Dealing
Announcement provided by
One Health Group PLC · OHGR11/03/2025 15:32

11 March 2025
One Health Group plc
("One Health" or the "Company")
Director Dealing
One Health Group plc (AQSE: OHGR), a provider of NHS-funded medical procedures, announces that further to the details set out in the circular to shareholders dated 20 February 2025, Derek Bickerstaff, Non-Executive Chairman of One Health, has notified the Company that he has transferred 1,100,000 ordinary shares of
Additionally, Shantanu Shahane, Chief Medical Officer of One Health, has notified the Company that he has transferred 35,000 Ordinary Shares to his wife and person closely associated, Angela Shahane.
Following the above transactions, the number and beneficial ownership of Ordinary Shares held by Mr Bickerstaff and Mr Shahane and persons closely related are unchanged.
For more information, please contact:
One Health Group plc Derek Bickerstaff, Chairman Adam Binns, CEO
|
via Square1 Consulting |
Panmure Liberum (Corporate Adviser, Nominated Adviser and Sole Bookrunner) Emma Earl, Will Goode, Mark Rogers, Joshua Borlant Rupert Dearden
|
Tel: +44 (0) 20 3100 2000 |
Square1 Consulting David Bick |
Tel: +44 207 929 5599 +44 7831 381201 |
|
|
Further information on the Company can be found on its website at www.onehealth.co.uk.
This announcement should be read in its entirety. In particular, the information in the "Important Notices" section of the announcement should be read and understood.
About One Health Group plc
One Health engages over 70 NHS Consultants (excluding anaesthetists) who sub-specialise in the various surgeries offered by the Company, through a growing network of community-based outreach clinics and surgical operating locations. One Health continues to deliver strong growth and in the year to March 2024 provided much needed care to 13,266 new patients, through almost 34,000 consultations and over 6,000 surgical procedures. One Health deploys surgeons and anaesthetists that are mostly employed by the NHS, on a subcontracted basis. It currently works with over 100 professionals across 9 independent hospitals and 37 outreach clinics. Within these community-based outreach clinics all consultations and post operative physiotherapy is delivered where required, reducing patient inconvenience and excess travel.
One Health's activities are focused on areas where NHS patient needs are under-supplied by the local NHS service, population density is relatively high and the level of private medical insurance or the ability to self-fund is relatively low. One Health has also sought to expand geographically from its Head Office in
One Health's business model has focused to date on four main areas: orthopaedics, spine, general surgery and gynaecology. The split of inpatient procedures in the year to 31 March 2024 was as follows: orthopaedics 46% spine 22% general surgery 22% gynaecology 10%.
Spine and orthopaedics are particularly attractive areas for One Health as the Directors believe that they benefit from powerful growth drivers in terms of an ageing demographic, physical inactivity and an increasing proportion of the population being categorised as obese. Within orthopaedics, the most common surgeries performed by One Health are knee and hip replacements.
*(https://www.onehealth.co.uk/investors)
The Directors of One Health Group plc accept responsibility for the contents of this announcement
Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them.
1. |
Details of the person discharging managerial responsibilities/person closely associated |
|
a) |
Name: |
Shantanu Shahane |
2. |
Reason for the notification |
|
a) |
Position/status: |
Chief Medical Officer |
b |
Initial notification/Amendment: |
Initial notification |
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name: |
One Health Group plc |
b) |
LEI: |
984500DC689F5BAD8732 |
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument: |
Ordinary shares of |
b) |
Nature of the transaction: |
Sale of shares |
c) |
Price(s) and Volume (s): |
Sale price(s). Nil Volume(s): 35,000 |
d) |
Aggregated Information: |
N/A |
e) |
Date of the transaction: |
10 March 2025 |
f) |
Place of the transaction |
Aquis (AQSE) |
1. |
Details of the person discharging managerial responsibilities/person closely associated |
|
a) |
Name: |
Angela Shahane |
2. |
Reason for the notification |
|
a) |
Position/status: |
Person closely associated with Shantanu Shahane, Chief Medical Officer |
b |
Initial notification/Amendment: |
Initial notification |
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name: |
One Health Group plc |
b) |
LEI: |
984500DC689F5BAD8732 |
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument: |
Ordinary shares of |
b) |
Nature of the transaction: |
Purchase of shares
|
c) |
Price(s) and Volume (s): |
Purchase price(s). Nil Volume(s): 35,000 |
d) |
Aggregated Information: |
N/A |
e) |
Date of the transaction: |
10 March 2025 |
f) |
Place of the transaction |
Aquis (AQSE) |
1. |
Details of the person discharging managerial responsibilities/person closely associated |
|
a) |
Name: |
Derek Bickerstaff |
2. |
Reason for the notification |
|
a) |
Position/status: |
Non-Executive Chairman |
b |
Initial notification/Amendment: |
Initial notification |
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name: |
One Health Group plc |
b) |
LEI: |
984500DC689F5BAD8732 |
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument: |
Ordinary shares of |
b) |
Nature of the transaction: |
Sale of shares |
c) |
Price(s) and Volume (s): |
Sale price(s). Nil Volume(s): 1,100,000 |
d) |
Aggregated Information: |
N/A |
e) |
Date of the transaction: |
10 March 2025 |
f) |
Place of the transaction |
Aquis (AQSE) |
1. |
Details of the person discharging managerial responsibilities/person closely associated |
|
a) |
Name: |
Michelle Bickerstaff |
2. |
Reason for the notification |
|
a) |
Position/status: |
Person closely associated with Derek Bickerstaff, Non-Executive Chairman |
b |
Initial notification/Amendment: |
Initial notification |
3. |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
|
a) |
Name: |
One Health Group plc |
b) |
LEI: |
984500DC689F5BAD8732 |
4. |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
|
a) |
Description of the financial instrument, type of instrument: |
Ordinary shares of |
b) |
Nature of the transaction: |
Purchase of shares
|
c) |
Price(s) and Volume (s): |
Purchase price(s). Nil Volume(s): 1,100,000 |
d) |
Aggregated Information: |
N/A |
e) |
Date of the transaction: |
10 March 2025 |
f) |
Place of the transaction |
Aquis (AQSE) |
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.